» Authors » Mark S Gresnigt

Mark S Gresnigt

Explore the profile of Mark S Gresnigt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 3439
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Praetorius J, Hitzler S, Gresnigt M, Figge M
FEMS Yeast Res . 2025 Mar; PMID: 40082735
The formation of hyphae is one of the most crucial virulence traits the human pathogenic fungus Candida albicans possesses. The assessment of hyphal length in response to various stimuli, such...
2.
Koceva H, Amiratashani M, Akbarimoghaddam P, Hoffmann B, Zhurgenbayeva G, Gresnigt M, et al.
Open Biol . 2025 Mar; 15(3):240231. PMID: 40037530
The lung microbiome has recently gained attention for potentially affecting respiratory viral infections, including influenza A virus, respiratory syncytial virus (RSV) and SARS-CoV-2. We will discuss the complexities of the...
3.
Rosati D, Valentine M, Bruno M, Pradhan A, Dietschmann A, Jaeger M, et al.
Virulence . 2025 Jan; 16(1):2451165. PMID: 39843417
Vulvovaginal candidiasis (VVC) is one of the most common infections caused by . VVC is characterized by an inadequate hyperinflammatory response and clinical symptoms associated with colonization of the vaginal...
4.
Hitzler S, Fernandez-Fernandez C, Fernandez C, Montano D, Dietschmann A, Gresnigt M
FEMS Microbiol Rev . 2024 Dec; 49. PMID: 39732621
Pathogenic microorganisms can infect a variety of niches in the human body. During infection, these microbes can only persist if they adapt adequately to the dynamic host environment and the...
5.
Kaden T, Alonso-Roman R, Stallhofer J, Gresnigt M, Hube B, Mosig A
Adv Healthc Mater . 2024 Nov; :e2402756. PMID: 39491534
Inflammatory bowel disease (IBD) is an idiopathic gastrointestinal disease with drastically increasing incidence rates. Due to its multifactorial etiology, a precise investigation of the pathogenesis is extremely difficult. Although reductionist...
6.
Cheng K, Montano D, Zelante T, Dietschmann A, Gresnigt M
Oxf Open Immunol . 2024 Sep; 5(1):iqae010. PMID: 39234208
Protective immunity to opportunistic fungal infections consists of tightly regulated innate and adaptive immune responses that clear the infection. Immune responses to infections of the vaginal mucosa by species are,...
7.
Schaefer S, Vij R, Sprague J, Austermeier S, Dinh H, Judzewitsch P, et al.
Nat Commun . 2024 Aug; 15(1):6818. PMID: 39122699
More than two million people worldwide are affected by life-threatening, invasive fungal infections annually. Candida species are the most common cause of nosocomial, invasive fungal infections and are associated with...
8.
Alonso-Roman R, Mosig A, Figge M, Papenfort K, Eggeling C, Schacher F, et al.
Nat Microbiol . 2024 Mar; 9(4):891-904. PMID: 38528150
Research on microbial pathogens has traditionally relied on animal and cell culture models to mimic infection processes in the host. Over recent years, developments in microfluidics and bioengineering have led...
9.
Jaeger M, Dietschmann A, Austermeier S, Dincer S, Porschitz P, Vornholz L, et al.
Virulence . 2024 Mar; 15(1):2333367. PMID: 38515333
Our immune system possesses sophisticated mechanisms to cope with invading microorganisms, while pathogens evolve strategies to deal with threats imposed by host immunity. Human plasma protein α1-antitrypsin (AAT) exhibits pleiotropic...
10.
Kaden T, Alonso-Roman R, Akbarimoghaddam P, Mosig A, Graf K, Raasch M, et al.
Biomaterials . 2024 Mar; 307:122525. PMID: 38489910
Candida albicans is a commensal yeast of the human intestinal microbiota that, under predisposing conditions, can become pathogenic and cause life-threatening systemic infections (candidiasis). Fungal-host interactions during candidiasis are commonly...